Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2

Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2

Abstract mRNA vaccines represent a promising alternative to conventional vaccines, as demonstrated by the rapid deployment of mRNA vaccines during the recent COVID-19 pandemic. In this work, we have adapted and fine-tuned various reported mRNA lipid nanoparticle (LNP) synthesis and preparation proce...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiin Felgner, Jenny E. Hernandez-Davies, Erwin Strahsburger, Emily Silzel, Rie Nakajima, Aarti Jain, Jacob Laster, Jui-Lin Chiang, Yali Tsai, Philip L. Felgner, D. Huw Davies, Li Liang
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01153-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41541-025-01153-6

Similar Items